Michael W. Dunne's Net Worth
$89.7 Thousand
Who is Michael W. Dunne?
Michael W. Dunne does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Aviragen Therapeutics, Inc., Iterum Therapeutics plc, and Durata Therapeutics, Inc..
SEC CIK
Michael W. Dunne's CIK is 0001553593
Past Insider Trading and Trends
2018 was Michael W. Dunne's most active year for acquiring shares with 8 total transactions. Michael W. Dunne's most active month to acquire stocks was the month of April. 2014 was Michael W. Dunne's most active year for disposing of shares, totalling 6 transactions. Michael W. Dunne's most active month to dispose stocks was the month of October. 2013 saw Michael W. Dunne paying a total of $374,500.00 for 50,000 shares, this is the most they've acquired in one year. In 2021 Michael W. Dunne cashed out on 33,143 shares for a total of $57,337.39, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aviragen Therapeutics, Inc. (VXRT) Snapshot price: $1.1815
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
| No matching records found | |||||||||
Iterum Therapeutics plc (ITRM) Snapshot price: $1.73
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.17% | 25K |
$1.40 | $35,000.00 | 113.75K |
Dec 22
| |||
Form 4
| +12.70% | 10K |
$1.84 | $18,442.00 | 88.75K |
Dec 18
| |||
Form 4
| +34.04% | 20K |
$2.03 | $40,690.00 | 78.75K |
Nov 22
| |||
Form 4
| +6.31% | 3.49K |
—
|
—
| 58.75K |
Oct 1
| |||
Form 4
| +3.33% | 1.78K |
—
|
—
| 55.27K |
Jul 1
| |||
Form 4
| +42.12% | 15.85K |
—
|
—
| 53.49K |
Jun 15
| |||
Form 4/A
| +3.57% | 1.3K |
—
|
—
| 37.63K |
Apr 1
| |||
Form 4
| +3.57% | 1.3K |
—
|
—
| 37.64K |
Apr 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +2.14% | 761 |
—
|
—
| 36.34K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
| +39.10% | 10K |
$2.22 | $22,200.00 | 35.58K |
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
| +10.61% | 36.8K |
—
|
—
| 383.65K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +3.12% | 10.49K |
—
|
—
| 346.85K |
Mar 25
| |||
Form 4
| +31.21% | 80K |
—
|
—
| 336.36K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
| +22.37% | 46.86K |
$1.73 | -$57,337.39 | 256.36K |
Jan 25 - Jan 26
| |||
Form 4
| +41.59% | 61.54K |
—
|
—
| 209.5K |
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +0.34% | 500 |
$10.00 | $5,000.00 | 147.96K |
Sep 4
| |||
Form 4
| +0.68% | 1K |
$10.00 | $10,000.00 | 147.46K |
Aug 24 - Aug 27
| |||
Form 4
| +17.39% | 21.7K |
$13.00 |
—
| 146.46K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Durata Therapeutics, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.22K |
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
∞
| 11.22K |
—
|
—
| 11.22K |
Mar 15 - Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||